Trials / Sponsors / PDL BioPharma, Inc.
PDL BioPharma, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizu Ulcerative Colitis | — | 2006-09-01 |
| Terminated | A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rhe Arthritis, Rheumatoid | Phase 2 | 2005-12-01 |
| Completed | Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Multiple Sclerosis | Phase 2 | 2005-04-01 |
| Completed | Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemothe Melanoma, Metastases | Phase 2 | 2004-12-01 |
| Unknown | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2000-10-01 |